We admire start-ups but resent big-corporations (unless they’re ). We idolize entrepreneurs, we’re wary of businessmen, and we vilify CEOs. Do we love business – or hate it? This depends a lot on what you mean by “business.” There are at least two competing narratives – the story of business as what you might call [...]
Read More...
Read the complete post at http://www.forbes.com/sites/davidshaywitz/2012/02/17/good-start-up-bad-corporation-the-cost-of-trading-passion-for-process/
Posted
Feb 17 2012, 01:53 AM
by
Health. Care.
Filed under: Apple, Mitt Romney, Facebook, Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Management, Tony Hsieh, entrepreneur, McKinsey & Company, David Brooks, Howard Schultz, Building the Organization of Tomorrow, ticker=NASDAQ:AAPL, ticker=NASDAQ:SBUX, Startup company